Product Reports Resources Pricing Login Book a demo

Acclarent

Biotech & Life Sciences · Menlo Park, United States · Founded 2004

Acclarent, a subsidiary of Johnson & Johnson Medical Devices Companies, specializes in developing minimally invasive ear, nose, and throat (ENT) solutions. The company primarily serves healthcare providers, including hospitals and specialized ENT clinics, by offering advanced medical devices designed to improve patient outcomes and streamline surgical procedures. Operating within the medical device industry, Acclarent focuses on innovation and the integration of cutting-edge technology to address common ENT issues such as chronic sinusitis and Eustachian tube dysfunction. The business model revolves around the research, development, and commercialization of these specialized devices, generating revenue through the sale of its products to medical institutions and practitioners. Acclarent leverages Johnson & Johnson's extensive distribution network and expertise in medical technology to maintain a competitive edge in the market. Keywords: ENT solutions, minimally invasive, medical devices, chronic sinusitis, Eustachian tube, healthcare providers, innovation, patient outcomes, surgical procedures, Johnson & Johnson.

Investors

6 investors on Acclarent's cap table

Sourced from Dealroom's funding history. Investor profile links are shown where available.

Seed 1 investor entered at this stage
ExploraMed
Series A 2 investors entered at this stage
Series B+ 3 investors entered at this stage
Meritech Capital
Delphi Ventures
Johnson & Johnson Development Corporation

Global footprint

Where Acclarent has talent and traffic

Workforce by country
3 countries with
team presence
🇺🇸 United States98.5%
🇸🇦 Saudi Arabia0.8%
🇧🇩 Bangladesh0.8%
3 countries shown

Talent graph

The shape of Acclarent's talent

Dealroom maps Acclarent's team person by person — pinpointing the standout operators and scoring them across the six dimensions investors underwrite. The counts and shape below are a public preview; the named individuals and exact scores live in the platform.

43 team members profilednamed & role-tagged by Dealroom
185 employeestotal headcount
1 executives & foundersidentified by name
DimensionScore
AI Talent Score hidden — book a demo
Engineering Score hidden — book a demo
Product Score hidden — book a demo
Go-to-market Score hidden — book a demo
Leadership Score hidden — book a demo
Research Score hidden — book a demo
Book a demo to unlock Acclarent's exact scores

Source: Dealroom Talent Intelligence. Public profiles show counts and the team's shape only — request a demo for the named individuals, per-person seniority and tenure, and team benchmarks vs peers.

Market sentiment

What the market is saying about Acclarent

An AI-synthesized read of the highest-engagement posts about Acclarent on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Acclarent on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.